Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

Clinical trial NCT01596699 · TERMINATED

Trial details

NCT number: NCT01596699
Sponsor: University of California, San Francisco
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myeloid Malignancy Bone Marrow Failure Syndrome Transfusion-dependent Red Blood Cell (RBC) Defect Congenital Immunodeficiency Metabolic Disease Severe Immune Dysregulation

Start date: 2012-05-24
Primary completion: 2019-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.